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http://www.biomedcentral.com/1756-0500/5/345RESEARCH ARTICLE Open AccessThe association between Acute Lymphoblastic
Leukemia in children and Helicobacter pylori as
the marker for sanitation
Pengiran Hishamuddin*Abstract
Background: Greaves “delayed infection” hypothesis suggested that Acute Lymphoblastic Leukemia (ALL) in
children is caused by a lack of exposure to infection in infancy, which may be due higher standards of sanitation.
We have conducted an ecologic analysis of the relationship between sanitation, using Helicobacter pylori (H. pylori)
as the marker, and the incidence of childhood ALL in 127 cancer registries from 28 countries.
Results: There were inverse associations between H. pylori prevalence and ALL incidence rates in children. These
associations were minor and only significant for ALL incidence rates for all cancer registries. They became
non-significant and smaller in magnitude when the population source and/or the GNP per capita were added to
the relationship. Furthermore, these results were unchanged when the associations were examined using the
Generalized Estimating Equations.
Conclusions: Although the findings showed lower prevalence of H. pylori and improved sanitation is associated
with increased incidence of childhood ALL, they do not conclusively support Greaves “delayed infection”
hypothesis.
Keywords: Public health, Epidemiology, OncologyBackground
Leukemia is the most common cancer in children [1].
The major types of childhood leukemia are acute
lymphoblastic leukemia (ALL) and acute myeloid
leukemia (AML) [1,2]. ALL accounts for the majority of
childhood leukemia [1,2]. The incidence of childhood
ALL has increased over the past 20 years [1,2]. This trend
is more apparent among 2 to 5 years and in developed
countries [1-3].
Genetic alterations occurring during fetal development
increase the risk of childhood ALL [4,5]. However, these
genetic factors are insufficient for leukemogenesis, which
appears to require a “second hit” [6]. One potential
mechanisms of such “second hit” transition is proposed
by the “delayed infection” (or Greaves) hypothesis [7].
According to the Greaves’ hypothesis, ALL in children is
caused by a lack of exposure to infections in infancy.Correspondence: hishamuddin_badaruddin@moh.gov.sg
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reproduction in any medium, provided the orThis inadequate exposure to infections in infancy leads
to failure of modulation in the immune system, which
involves changes to certain T-cells [7]. Exposure to one
or more common bacterial or viral infections later in
life, for example after mixing with carriers such as chil-
dren in playgroups or schools [8,9], then results in an
abnormal immune response and eventually ALL. This
delayed infection may be due to improved sanitary con-
ditions found in modern lifestyles [7]. Greaves’ “delayed
infection” hypothesis is conceptually similar to the “hy-
giene hypothesis” that has been proposed to explain al-
lergies, asthma and type 1 diabetes [10]. The “hygiene
hypothesis” suggests that early childhood infections are
needed to promote the development of the immune sys-
tem and to suppress allergic and autoimmune disorders.
This study examines Greaves’ “delayed infection” hy-
pothesis by looking at whether level of sanitation is asso-
ciated with the incidence rates of childhood ALL in
different countries. In this study we use Helicobacter pylori
(H. pylori) as a marker of sanitation. H. pylori is an ubi-
quitous bacterium affecting a large percentage of thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in people who reside in conditions with inadequate
saniation [12]. Therefore, lower prevalence of H. pylori is
associated with improved sanitation and lack of exposure
to infections. Under the “delayed infection” hypothesis
countries with lower prevalence of H. pylori are expected




The ALL incidence rates (per 100, 000 persons) in 0 to 4
years old children obtained from the monograph, Cancer
Incidence in Five Continents, Volume VIII, published
jointly by the International Agency for Research on Cancer
(IARC) and the International Association of Cancer
Registries (IARC) [13]. Data were available from 185 can-
cer registries in 56 countries. However, the analyses were
confined to those countries in which corresponding
H. pylori prevalence rates for children were available. These
comprised 28 countries that include 127 cancer registries.
All the data were collected between 1991 and 1998, with
the majority (78%) collected between 1993 and 1997.
Weighted ALL incidence rates
Weighted ALL incidence rates, which is the pooled esti-
mate of the ALL incidence rates for cancer registries in a
country, were calculated using the inverse variance
method where larger studies are given more weight than
smaller studies [14]. If Ii, (i = 1,2 . . .), is the ALL inci-
dence rate for the ith cancer registry in a country, then
the weighted ALL incidence rate for the entire country is
defined as (
P
Ii wi) / (
P
wi), where the registry-specific
weight (wi) equals 1/(si
2) and si
2 represents the variance of
the Ii estimate. As ALL incidence rates are binomially
distributed, the variance (si
2) for the ALL incidence rate
for each individual cancer registry was obtained using
the formula s2i = ni Ii (1-Ii), where ni (i = 1, 2 . . .) is the
population size of children aged 0 to 4 years old in the ith
cancer registry, and Ii (i = 1, 2 . . .) is the ALL incidence
rate for the ith cancer registry in a country [15].
H. pylori prevalence rates
The prevalence rates (per 100 persons) of H. pylori in-
fection in children from 26 countries were obtained
from studies reviewed by Torres et al [16]. To supple-
ment these data, a Medline search of articles using the
search term Helicobacter pylori and prevalence was con-
ducted and H. pylori prevalence rates for two additional
countries, Singapore [17] and Thailand [18], were found.
Only one H. pylori prevalence rate, for children be-
tween 0 to 10 years old was used for each country. The
prevalence rates/studies included in the analyses were
selected based on the following criteria: Studies which looked exclusively at infants aged 0 to
1 years old were excluded, as the H. pylori
prevalence in this age group, especially when
measured using the serological assays, could be
influenced by maternal IgG antibodies that were
transferred to the child [16].
 The maximum age of children in the studies was
limited to 10 years old as the most relevant group
for ALL children is under this age [1-3].
 Studies with children 1 to 4 years old were
preferred, and if this was not available then the next
youngest age group was selected.
Covariates
Certain characteristics of the H. pylori studies were con-
sidered as potential confounders. All H. pylori surveys
were characterized as either clinic-based or population-
based. Clinic-based surveys can be affected by selection
bias because participants in these studies may have
higher socioeconomic status and live in better sanitary
conditions [16]. As a result H. pylori prevalence rates are
more likely to be lower in clinic-based samples. Another
potential confounder was the method of H. pylori detec-
tion. The studies used either the urea breath test or
serological assays of IgG antibodies. The H. pylori preva-
lence rates differ depending on which method was uti-
lized, and this is due to the different sensitivities and
specificities associated with these diagnostic tests [19].
The degree of urbanization in the area where the studies
were conducted was also a potential confounder as
H. pylori prevalence rates have been shown to be
higher in more urban areas [16]. The minimum and
maximum ages of children in the studies, were con-
sidered potential confounders as H. pylori prevalence
rates and ALL incidence rates are known to change
according to age groups [16]. H. pylori prevalence
rates also vary according to geographic locations
[16,19], and therefore the regional location of a
country was considered a potential confounder. To
examine this, all countries that provided the data for
analyses were categorized according to the World
Health Organization (WHO) regions [20]. The data
for each country also included the interval between
the year of the ALL incidence and the year when the
H. pylori survey was conducted.
Characteristics of the countries considered in this study
included the Gross National Product (GNP) per capita,
Human Development Index (HDI) and the population
size. GNP per capita is defined as the dollar value of a
country’s final output of goods and services in a year,
divided by its population size [21]. This reflects the aver-
age income of a country’s citizens. HDI measures a coun-
try’s average achievements in human development [22].
It consists of three components – life expectancy at birth,
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the Gross Domestic Product per capita. GNP per capita
and HDI are considered to be markers for the level of af-
fluence and development of a country, and also potential
confounders for H. pylori prevalence and ALL incidence
rates. This is because countries with higher GNP per
capita and HDI typically have improved levels of sanita-
tion and healthcare, and are likely to have lower H. pylori
prevalence and higher ALL incidence rates. For each
country, the analytic dataset included the GNP per capita
and the population size corresponding to the year the
H. pylori study [21]. The United Nations Development
Program releases HDI data every 5 years [22]. The specific
HDI value was selected based in its proximity to the
H. pylori survey.Statistical analyses
The ALL incidence rates were considered using two
methods: the weighted method combined the data from
all cancer registries is each country (n = 28) and the non-
weighted method included data from each cancer regis-
try separately (n = 127). The H. pylori prevalence rate
was continuously entered into all the models.
The minimum and maximum age of children in the
H. pylori studies, the interval between the ALL inci-
dence and H. pylori surveys, the GNP per capita, the
HDI, and the population size were treated as continuous
variables. The method of H. pylori detection (urea
breath test versus serological assay), the population
source (clinic-based versus community-based), the level
of urbanization (urban, rural or both) and the WHO re-
gion (Africa, Americas, South East Asia, Europe and
Western Pacific) were treated as categorical variables.
All analyses were performed using the software SAS
9.1.3.Univariate analyses
PROC UNIVARIATE was used to look at the normal
distributions, mean, median, and standard deviation of
all continuous variables. PROC FREQ was used to pro-
duce counts and cross tabulation tables for all categor-
ical variables. Both the continuous and categorical
variables were examined for missing values and extreme
outliers.
Both outcome variables (the weighted ALL incidence
rates for each country and the ALL incidence rates for
all cancer registries) were normally distributed. Only one
other continuous covariate, the interval between ALL in-
cidence and H. pylori surveys, was normally distributed.
No issues with regards to missing values were found in
all the continuous and categorical variables. No pro-
blems with extreme outliers were identified in continu-
ous variables.Bivariate analyses
All bivariate analyses were performed twice, initially with
the weighted ALL incidence rate for each country
(n = 28) and then repeated with the ALL incidence rate
for all cancer registries (n = 127) in the model. PROC
CORR was used to perform correlations between:
 Both outcome variables and the H. pylori prevalence
rates.
 Both outcome variables and the other continuous
covariates.
 The H. pylori prevalence rates and the other
continuous covariates.
 The other continuous covariates with each other.
The r2 value, which denotes the percentage of variation
in the dependent outcome variable which is accounted for
by the independent exposure variable or covariates, and
the significance of the correlation (p-value of less than
0.05) was looked at. Pearson’s method was used to look at
the correlation between both outcome variables and the
interval between ALL incidence and H. pylori surveys.
This method was applied as both the outcome variables
and this continuous covariate were normally distributed.
Spearman’s method was used for all other correlations as
at least one continuous variable then was not normally
distributed. For categorical variables, PROC GLM or
PROC ANOVA was performed to look at the mean,
standard deviation and significance (p-value of less than
0.05) of the prevalence of both outcome variables, H. pylori
prevalence rate, the other continuous and categorical
covariates, in each category of the categorical covariates.
Bivariate analyses: the correlations between ALL incidence,
H. pylori prevalence and characteristics of H. pylori studies/
countries (n = 28)
The correlations between all continuous variables when
the weighted ALL incidence rates for each country
(n = 28) were modeled were calculated using PROC
CORR. Pearson’s method was used for the correlation
between the weighted ALL incidence rates for each
country and the interval between the ALL incidence and
the H. pylori surveys, as both these variables were nor-
mally distributed. Spearman’s method was used for all
other correlations as at least one continuous variable
then was not normally distributed. The weighted ALL
incidence rates for each country was negatively correlated
to the H. pylori prevalence rates but this was not significant
(r2 =−0.14, p-value =0.48). The covariates which were not
significantly correlated with both the weighted ALL inci-
dence rates for each country and the H. pylori prevalence
rates were the minimum and maximum age of children in
the H. pylori studies, the interval between the ALL inci-
dence and the H. pylori surveys and the population size of
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excluded from the model. Significant correlations identify-
ing potential confounders were:
 H. pylori prevalence rates and GNP per capita
(r2 =−0.60, p-value = 0.0007).
 H. pylori prevalence rates and HDI (r2 =−0.57,
p-value = 0.002).
Significant correlation identifying potential collinearity
was:
 GNP per capita and HDI (r2 = 0.95, p-value=<0.0001)
Bivariate analyses: the correlations between ALL incidence,
H. pylori prevalence and characteristics of H. pylori studies/
countries (n = 127)
The correlations between all continuous variables when the
ALL incidence rates for all cancer registries in all countries
(n=127) were modeled were calculated using PROC
CORR. Pearson’s method was used for the correlations be-
tween the ALL incidence rates for all cancer registries in all
countries and the interval between the ALL incidence and
the H. pylori surveys, as both these variables were normally
distributed. Spearman’s method was used for all other cor-
relations as at least one continuous variable then was not
normally distributed. The ALL incidence rates for all cancer
registries in all countries was negatively correlated to the
H. pylori prevalence rates but this was not significant
(r2 = −0.17, p-value = 0.05). The covariates which were
not significantly correlated with both the ALL incidence
rates for all cancer registries and the H. pylori prevalence
rates were the maximum age of children in the H. pylori
studies and the interval between the ALL incidence and
the H. pylori surveys. These 2 covariates could potentially
be excluded from the model.
Significant correlations identifying potential confoun-
ders were:
 ALL incidence rates for all cancer registries and
GNP per capita (r2 = 0.38, p-value = <0.0001)
 ALL incidence rates for all cancer registries and HDI
(r2 = 0.41, p-value = <0.0001)
 ALL incidence rates for all cancer registries and
population size of countries (r2 =−0.21, p-value=0.019).
 H. pylori prevalence rates and GNP per capita
(r2 =−0.43, p-value = <0.0001).
 H. pylori prevalence rates and the HDI (r2 =−0.40,
p-value = <0.0001).
 H. pylori prevalence rates and the population size of
countries (r2 = 0.54, p-value = <0.0001).
 H. pylori prevalence rates and the minimum age of
children in the H. pylori studies (r2 = 0.24,
p-value = 0.003).Significant correlations identifying potential collinear-
ity were:
 GNP per capita and the HDI (r2 = 0.97,
p-value = <0.0001).
 GNP per capita and population size (r2 =−0.25,
p-value = 0.005).
 HDI and population size of countries (r2 =−0.26,
p-value = 0.003).
Bivariate analyses: the relation of ALL incidence, H. pylori
prevalence, the minimum and maximum age of children, the
interval between ALL incidence and H. pylori surveys, GNP per
capita, HDI and population size to various characteristics of
H. pylori studies (n=28)
PROC GLM was performed to look at the mean, stand-
ard deviation and significance (p-value of less than 0.05)
of the prevalence of the weighted ALL incidence rates
for each country, the H. pylori prevalence rates and the
other continuous covariates, in each category of the cat-
egorical covariates (which were certain characteristics of
the H. pylori studies). The prevalence of both the
weighted ALL incidence rates for each country and the
H. pylori prevalence rates was not significant in the
method of H. pylori used in the H. pylori studies. This
covariate could potentially be excluded from the model.
Significant associations identifying potential confoun-
ders were:
 The prevalence of H. pylori prevalence rates in the
population source used in the H. pylori survey
(p = 0.04), the level of urbanization in the H. pylori
studies (p = 0.02) and the region a country is
situated (p = 0.0003).
Significant associations identifying potential collinear-
ity were:
 The prevalence of GNP per capita in the level of
urbanization in the H. pylori studies (p = 0.02).
 The prevalence of HDI in the level of urbanization
in the H. pylori studies (p = 0.008) and the region a
country is situated (p = <0.0001).
Bivariate analyses: the relation of ALL incidence, H. pylori
prevalence, the minimum and maximum age of children, the
interval between ALL incidence and H. pylori surveys, GNP per
capita, HDI and population size to various characteristics of
H. pylori studies (n=127)
PROC GLM were performed to look at the mean, stand-
ard deviation and significance (p-value of less than 0.05)
of the prevalence of the ALL incidence rates for all can-
cer registries, the H. pylori prevalence rates and the
other continuous covariates, in each category of the
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of the H. pylori studies). The prevalence of both the
ALL incidence rates for all cancer registries and the
H. pylori prevalence rates was not significant in the method
of H. pylori detection used in the H. pylori studies. This
covariate could potentially be excluded from the model.
Significant associations identifying potential confoun-
ders were:
 The prevalence of the ALL incidence rates for all
cancer registries in the population source used in
the H. pylori survey (p = 0.038), the level of
urbanization in the H. pylori studies (p = 0.002) and
the region a country is situated (p = 0.0008).
 The prevalence of H. pylori prevalence rates in the
population source used in the H. pylori survey
(p = <0.0001), the level of urbanization in the
H. pylori studies (p = <0.0001) and the region a
country is situated (p = <0.0001).
Significant associations identifying potential collinear-
ity were:
 The prevalence of GNP per capita in the level of
urbanization in the H. pylori studies (p = <0.0001)
and the region a country is situated (p = <0.0001).
 The prevalence of HDI in the population source
used in the H. pylori survey (p = 0.004), the level of
urbanization in the H. pylori studies (p = <0.0001)
and the region a country is situated (p = <0.0001).
 The prevalence of the population size of countries in
the population source used in the H. pylori survey
(p= 0.0006), the level of urbanization in the H. pylori
studies (p= <0.0001) and the region a country is
situated (p=<0.0001).
Bivariate analyses: the associations among various
characteristics of H. pylori studies (n = 28)
PROC ANOVA were performed to look at the mean,
standard deviation and significance (p-value of less than
o.05) of the prevalence of the categorical covariates in
each other, when the weighted ALL incidence rates in
each country was modeled.
Significant associations identifying potential collinear-
ity was:
 The prevalence of the population source used in the
H. pylori survey in the level of urbanization in the
H. pylori studies (p = 0.007).
Bivariate analyses: the associations among various
characteristics of H. pylori studies (n = 127)
PROC ANOVA were performed to look at the mean,
standard deviation and significance (p-value of less than0.05) of the prevalence of the categorical covariates in
each other, when the ALL incidence rates in all cancer
registries were modeled.
Significant associations identifying potential collinear-
ity were:
 The population source used in the H. pylori survey
in the level of urbanization in the H. pylori studies
(p = <0.0001).
 The level of urbanization in the H. pylori studies in
the population source used in the H. pylori survey
(p = 0.002) and the region a country is situated
(p = <0.0001).
Covariates or confounders excluded from further analyses
Covariates which were not correlated or associated with
either H. pylori prevalence of ALL incidence rates were
not included in the model. The confounders that
remained were examined for collinearity. When this
existed one confounder was chosen to be included in
the model based on the strength of its correlation or as-
sociation to either H. pylori prevalence or ALL incidence
rates.
Continuous covariates or confounders excluded from
further analyses
GNP per capita and the HDI were positively correlated
with ALL incidence rates. This correlation was not sig-
nificant when weighted ALL incidence rates were mod-
eled (GNP per capita: r2 = 0.22, p-value = 0.26; HDI:
r2 = 0.18, p-value = 0.36) but was significant when the
ALL incidence rates for all cancer registries were mod-
eled (GNP per capita: r2 = 0.38, p-value = <0.0001; HDI:
r2 = 0.41, p-value = <0.0001). GNP per capita and the
HDI were negatively correlated with the H. pylori preva-
lence rates. For example, when the ALL incidence rates
for all cancer registries were used as the outcome vari-
able, the correlation between H. pylori prevalence rates
and GNP per capita had a r2 of −0.43 and a p-value of
<0.0001 whereas the correlation between H. pylori preva-
lence rates and HDI had a r2 of −0.40 and a p-value of
<0.0001. GNP per capita and HDI were highly cor-
related to each other. For example, when the
weighted ALL incidence rates for each country were
used in the model, the correlation between these
two was significantly positive with a r2 of 0.95 and
a p-value of <0.0001. This meant that both covariates
could not be considered in the same model as doing so
might lead to potential collinearity. GNP per capita was
the covariate used in the further analyses based on its
higher correlation to the H. pylori prevalence and ALL
incidence rates.
The population size of the countries was negatively cor-
related with the ALL incidence rates. This correlation was
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registries were modeled (r2 =−0.21, p-value =0.019). The
population size of countries was positively correlated with
the H. pylori prevalence rates. This correlation was signifi-
cant when the outcome variable was the ALL incidence
rates in all cancer registries (r2 = 0.54, p-value =<0.0001).
The population size of a country was negatively correlated
with a confounder, GNP per capita. This correlation was
significant when the ALL incidence rates for all cancer
registries were modeled (r2 =−0.25, p-value =0.005). This
is not surprising as the denominator in the calculation of
the GNP per capita of a country is its population size. The
population size of a country was therefore excluded from
further analysis.
The minimum age of children in the H. pylori studies
was positively correlated with the H. pylori prevalence
rates. This correlation was significant when the outcome
variable was the ALL incidence rates for all cancer regis-
tries (r2 = 0.24, p-value = 0.003). This covariate was not
consistently correlated with both ALL incidence rates.
When the weighted ALL incidence rates for each coun-
try were modeled, the correlation had a r2 of 0.34 with a
p-value of 0.08 and when the ALL incidence rates for all
cancer registries were modeled, the correlation had a r2
of −0.008 with a p-value of 0.93. Therefore, the mini-
mum age of children in the H. pylori studies was
excluded from further analysis.
The maximum age of children in the H. pylori studies
was not consistently correlated with both ALL incidence
rates. When the weighted ALL incidence rates for each
country were modeled, the correlation had a r2 of −0.23
with a p-value of 0.24 and when the ALL incidence rates
for all cancer registries were modeled, the correlation had
a r2 of 0.10 with a p-value of 0.29. This covariate was also
not consistently correlated with the H. pylori prevalence
rates. When the weighted ALL incidence rates for each
country were modeled, the correlation with the H. pylori
prevalence rates had a r2 of 0.24 with a p-value of 0.21 and
when the ALL incidence rates for all cancer registries were
modeled, the correlation with the H. pylori prevalence rates
had a r2 of −0.08 with a p-value of 0.38. Therefore, the
maximum age of children in the H. pylori studies was not
used in the further analysis.
The interval between the ALL incidence and the H. pylori
surveys was not consistently correlated with both ALL inci-
dence rates. When the weighted ALL incidence rates for
each country were modeled, the correlation had a r2 of 0.21
with a p-value of 0.27 and when the ALL incidence rates
for all cancer registries were modeled, the correlations had
a r2 of −0.15 with a p-value of 0.08. The interval between
the ALL incidence and the H. pylori surveys was not con-
sistently correlated with the H. pylori prevalence rates.
When the weighted ALL incidence rates for each country
were modeled, the correlation with the H. pylori prevalencerates had a r2 of −0.01 with a p-value of 0.94 and when the
outcome variable was the ALL incidence rates for all cancer
registries, the correlation with the H. pylori prevalence rates
had a r2 of −0.009 with a p-value of 0.92. Therefore the
interval between the ALL incidence and the H. pylori sur-
veys was not used in the further analysis. This meant that
the only continuous confounder in the model was GNP per
capita.
Categorical covariates or confounders excluded from
further analyses
The method of H. pylori detection used in the H. pylori
studies was not associated with H. pylori prevalence for
both ALL incidence rates. For example when the
weighted ALL incident rates for each country were mod-
eled, the association between the method of H. pylori
detection used in the H. pylori studies and the H. pylori
prevalence rates had a p-value of 0.14 and between the
method of H. pylori detection used in the H. pylori stud-
ies and ALL incidence rates had a p-value of 0.08. This
covariate was therefore excluded from further analysis.
The population source used in the H. pylori survey
was associated with ALL incidence rates for all cancer
registries (p-value = 0.038). The type of population
source used in the H. pylori survey was also associated
H. pylori prevalence rates for both outcomes. For ex-
ample, when the ALL incidence rates for all cancer
registries were modeled, the associations between the
population source used in the H. pylori survey and
H. pylori prevalence rates had a p-value of <0.0001.
The level of urbanization in the H. pylori studies was
associated with ALL incidence rates for all cancer registries
(p-value =0.002). The level of urbanization in the H. pylori
studies was also associated with H. pylori prevalence rates
for both outcomes. For example, when the ALL incidence
rate for all cancer registries were modeled, the association
between level of urbanization in the H. pylori studies and
the H. pylori prevalence rates had a p-value of <0.0001.
The region each country was situated in was asso-
ciated with ALL incidence rates for all cancer registries
(p-value = 0.0008). The region each country was situated
in was also associated H. pylori prevalence rates for both
outcomes. For example, when the ALL incidence rates
for all cancer registries were modeled, the association
between region each country was situated in and H. pylori
prevalence rates had a p-value of <0.0001.
The level of urbanization in the H. pylori studies and
the region each country was situated in were associated
with GNP per capita. For example when the ALL inci-
dence rates for all cancer registries were modeled, the
association between GNP per capita and the level of
urbanization in the H. pylori studies and between GNP
per capita and the region in each country was situated
both had a p-value of <0.0001. The level of urbanization
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situated in were excluded from further analyses as GNP
per capita had a higher correlation to the H. pylori
prevalence and ALL incidence rates.
Confounders included in further analyses
Therefore, confounders that remained and which did
not have collinearity with each other, were GNP per
capita (continuous) and the population source used in
the H. pylori survey (clinic-based or community-based
samples). These two confounders were included in the
final analyses.
Linear regression – unadjusted and adjusted analyses
The population source used in the H. pylori survey was
analyzed using a new categorical covariate (population1)
which was created using dummy variables, where the
reference group is community-based population sam-
ples. PROC REG was used to perform unadjusted linear
regression analyses between the outcome variables and
the H. pylori prevalence rates, and the confounders –
the GNP per capita and the population source used in
the H. pylori survey. PROC REG was then repeated to
perform adjusted linear regression analyses between the
outcome variables and the H. pylori prevalence rates,
controlling for both confounders separately, and then
simultaneously. For each step of the analyses the param-
eter estimate (coefficient), standard error and signifi-
cance (p-value of less than 0.05) was looked at. All linear
regression analyses were performed twice, initially with
the weighted ALL incidence rates for each country
(n = 28) as the outcome variable and then repeated with
the ALL incidence rates for all the cancer registries
(n = 127).
Generalized Estimating Equations
Generalized Estimating Equations (GEE) [14], were used
to assess the relationship between H. pylori prevalence
and ALL incidence rates among the 127 cancer regis-
tries in the 28 countries, accounting for the dependency
and repeated observations within countries. PROC
GENMOD was used to perform unadjusted analyses be-
tween the outcome variable (which in this method is
the ALL incidence rates in all cancer registries belong-
ing to the same country) and the H. pylori prevalence
rates, and the confounders – the GNP per capita and
the population source used in the H. pylori survey.
PROC GENMOD was then repeated to perform
adjusted analyses between the outcome variable and the
H. pylori prevalence rates, controlling for both confoun-
ders separately and then simultaneously. For each step
of the analyses the parameter estimate (coefficient),
standard error and significance (p-value of less than
0.05) was looked at.Regression diagnostics
The assumptions (that there is a linear relationship be-
tween the outcome and predictor variables and that the
errors are independent and normally distributed with a
mean of 0 and σ2) of the linear regression models were
examined by plotting:
 The values of the outcome variable against its
predicted values. This plot should look like a 45° line
when the X and Y axes are scaled the same.
 The studentized residuals against the predicted
values for the outcome variable. If the assumption
for the constant variance of errors is true then this
plot should show a random scatter about 0 and the
width of the scatter should be the same.
 The studentized residuals against the values of the
predictor variables. If the assumption for the
constant variance of errors is true then this plot
should show a random scatter about 0 and the
width of the scatter should be the same. This plot
was done for each predictor variable in the model.
 Normal probability plot of errors. This checks the
normality assumption.
In addition, issues with regards to influential outliers
and collinearity were addressed. The assumptions for
the linear regression models were met and there were
no issues with regards to influential outliers and
collinearity.
Ethical approval
As this study was an ecological study which utilized pre-
viously published data and which was not research in-
volving human subjects or animals, it required no
submission to IRB. This was determined in consultation
with the Communicable Diseases Division, Ministry of
Health, Singapore.
Results and discussion
The characteristics of the H. pylori studies are shown in
Table 1. These together with characteristics of countries
included in the analyses are described further in Table 2.
Weighted ALL incidence rates for each country (n = 28)
had a median of 16.40 per 100, 000 persons (standard
deviation = 11.75) as compared to the ALL incidence
rates for all cancer registries ( n = 127) which had a me-
dian of 21.25 per 100, 000 persons (standard deviation =
12.62). As for the H. pylori prevalence (%), this ranged
from 3% to 74% and had a median of 19.30%. The chil-
dren included in the H. pylori studies, had a median
minimum age of 1.50 years (standard deviation = 2.25
years), and a median maximum age of 5.00 years (stand-
ard deviation = 2.43 years). There were more studies
using serological assays (n = 25) than urea breath test












Algeria 45 0 9 42 Serology Clinic Urban 1987 Africa Megraud et al. [23]
Brazil 36.7 3 5 60 Serology Clinic Urban 1992 Americas Oliveira et al. [24]
Colombia 61 2 5 373 UBT Community Rural 1992 Americas Goodman et al. [25]
Costa Rica 60 7 10 60 Serology Community Rural 1984-1988 Americas Sierra et al. [26]
USA 35 1 5 182 Serology Clinic Both 1998 Americas Elitsur et al. [27]
China 53 3 4 19 UBT Community Rural 1994 Western Pacific Ma et al. [28]
India 6 3 10 30 Serology Clinic Urban 1989 Southeast Asia Graham et al. [29]
Japan 12.5 1 4 56 Serology Clinic Urban 1994 Western Pacific Matsukura et al. [30]
Korea 6 1 3 52 Serology Clinic Both 1998j Western Pacific Malaty et al. [31]
Vietnam 13 0 9 61 Serology Clinic Urban 1987 Western Pacific Megraud et al. [23]
Belgium 6.4 1 5 n/ae Serology Clinic Both 1995 j Europe Blecker et al. [32]
Estonia 4.9 9 9 94 Serology Community Both 1993-1996 Europe Vorobja et al. [33]
Finland 6 3 3 131 Serology Community Both 1980 Europe Ashorn et al. [34]
France 4 0 9 113 Serology Clinic Urban 1987 Europe Megraud et al. [23]
Germany 8.3 3 5 36 Serology Clinic Urban 1984 Europe Hornemann et al. [35]
Iceland 9 0 9 13 Serology Clinic Both 1991-1992 Europe Bergenzaum et al. [36]
Italy 22 1 10 32 Serology Clinic Urban 1995 Europe Luzza et al. [37]
Netherlands 9 6 8 80 Serology Clinic Urban 1993 Europe Roosendaal et al. [38]
Poland 16.6 3 5 60 Serology Clinic Urban 1996 Europe Czkwianianc et al. [39]
Portugal 42.6 3 6 n/ae Serology Clinic Urban 1994 j Europe Quina et al. [40]
Russia 30 1 4 44 Serology Community Urban 1996 Europe Malaty et.al [41]
Spain 11 2 9 203 Serology Clinic Both 1991-1992 Europe Cilla et al. [42]
Sweden 7.7 1 4 661 Serology Clinic Urban 1984-1995 Europe Grandstorm et al. [43]
Switzerland 7 5 7 432 UBT Community Both 1998 Europe Boltshauser et al. [44]
Australia 25 2 4 20 Serology Clinic Urban 1991 Western Pacific Hardikar et al. [45]
Gambia 31 0 5 353 Serology Community Rural 1990 Africa Sullivan et al. [46]
Singapore 3 0 4 305 Serology Community Urban 1992 Western Pacific [17]
Thailand 74 1 4 27 Serology Community Urban 1990 Southeast Asia Perez-Perez et al. [18]
a H. pylori prevalence (%).
b Minimum age of children in the studies.
c Maximum age of children in the studies.
d Number of children in the age group.
e Only the prevalence rate was available.
f Method of detection was either by serological assay using IgG (serology) or urea breath test (UBT).
g Population source was either clinic-based or community-based.
h Studies were conducted in urban, rural or both areas.
i The year the H. pylori study was done.
j The year H. pylori study was published.
k World Health Organization region a country is situated.
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twenty-eight H. pylori studies, eighteen were clinic-based
and ten were community-based surveys. Four studies
were conducted in urban areas, and only eight studies
were done in both settings. The average interval between
the ALL incidence and the H. pylori surveys was 4.1
years. Half of the studies were conducted in Europe
(n = 14), four studies were from the Americas (14.3%)
and six were from Western Pacific (21.4%). Only twostudies were from Africa (7.1%) and another two studies
were from South-East Asia (7.1%). The average GNP per
capita for the countries was US$11, 375.79, while the
average HDI for the countries was 0.80. In addition it
was noted that both the weighted ALL incidence rates
for each country (n = 28) and the ALL incidence rates for
all cancer registries (n = 127) were normally distributed.
Confounders which did not have any collinearity with
each other were GNP per capita (continuous) and the
Table 2 Descriptive statistics for characteristics of ALL incidence and H. pylori prevalence studies/countries
ALL incidence rate (per 100,000 persons) Mean Median s.d. b Frequency (%)
Weighted ALL incidence a (28 countries) 17.61 16.40 11.75 - -
Non-weighted ALL incidence rate (127 cancer registries) 21.68 21.25 12.62 - -
Characteristics of included countries (n = 28)
Gross National Product per capita for countries (USD$) 11375.79 9520.00 1182.10 - -
Human Development Index for countries 0.80 0.87 0.14 - -
Population size for countries 118137528 36416282 265588002 - -
Characteristics of H. pylori studies (n = 28)
H. pylori prevalence (%) 26.56 19.30 21.46 - -
Minimum age of children (years) 2.21 1.50 2.25 - -
Maximum age of children (years) 6.21 5.00 2.43 - -
Interval between ALL incidence and H. pylori surveys (years) 4.11 3.00 4.78 - -
Method of H. pylori detection
Serological assays using IgG - - - 25 89.29
Urea breath test - - - 3 10.71
Population source
Community-based - - - 10 35.71
Clinic-based - - - 18 64.29
Level of urbanization
Rural - - - 4 14.29
Urban - - - 16 57.14
Both rural and urban - - - 8 28.57
Region
Africa - - - 2 7.14
Americas - - - 4 14.29
Southeast Asia - - - 2 7.14
Europe - - - 14 50.00
Western Pacific - - - 6 21.43
a Weighted ALL incidence rate for each country was obtained using the inverse variance method.
b Standard deviation.
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based or community-based samples). These were
included in the further analyses.
There was a negative association between H. pylori
prevalence and ALL incidence rates. This was non-
significant when the weighted ALL incidence rates for
each country were used in the model (parameter esti-
mate =−0.10, standard error = 0.11, p-value = 0.35), How-
ever when the ALL incidence rates for all cancer
registries were modelled this association became signifi-
cant (parameter estimate =−0.14, standard error = 0.05,
p-value = 0.01, R2 = 0.0485).
There was a positive association between ALL inci-
dence rates and both confounders – the population
source in the H. pylori surveys and the GNP per
capita. This association was non-significant for the
weighted ALL incidence rates (the population source
used in the H. pylori surveys: parameter estimate =2.98, standard error = 4.69, p-value = 0.53; GNP per
capita: parameter estimate = 0.0001, standard error =
0.0002, p-value = 0.55), but became significant when
the ALL incidence rates for all cancer registries were
included separately (the population source used in the
H. pylori surveys: parameter estimate = 5.40, standard
error = 2.57, p-value = 0.04; GNP per capita: parameter
estimate = 0.0003, standard error = 0.00009, p-value =
0.0004, R2 = 0.0953).
The effect of the association between the ALL inci-
dence rates for all cancer registries and the H. pylori
prevalence rates were attenuated (became non-signifi-
cant) slightly when it was adjusted for the population
source used in the H. pylori surveys (parameter esti-
mate =−0.11, standard error = 0.06, p-value = 0.06). This
attenuation was more pronounced when the analysis
was adjusted for GNP per capita (parameter estimate =
−0.05, standard error = 0.06, p-value = 0.41) and changed
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http://www.biomedcentral.com/1756-0500/5/345further when the analysis was adjusted for both the
population source used in the H. pylori surveys and
GNP per capita (parameter estimate =−0.02, standard
error = 0.07, p-value = 0.82).
Generalized Estimating Equations (GEE) [14] were
used to assess the relationship between H. pylori preva-
lence and ALL incidence rates among the 127 cancer
registries in the 28 countries, accounting for the
repeated observations within countries. The results were
similar to the associations found in both the unadjusted
and adjusted linear regression analyses when the ALL in-
cidence rate for all cancer registries were modelled. For
example, the unadjusted analyses for the association be-
tween ALL incidence and H. pylori prevalence rates had
a parameter estimate of −0.14, standard error of 0.05
and p-value of 0.01 using both methods.
Conclusion
Smith et al. [47] showed that improved hygiene, as mea-
sured by decreased prevalence of Hepatitis A virus, is asso-
ciated with higher childhood ALL incidence rates. In our
study we examined whether the level of sanitation, using
H. pylori as the marker, is associated with incidence rates
of childhood ALL in different countries. Our analyses
demonstrated inverse association between H. pylori preva-
lence and ALL incidence rates in children. This implies
that countries, where children live in better sanitary condi-
tions and have lower H. pylori prevalence rates, are
expected to experience increased childhood ALL incidence
rates. However these associations were minor and only sig-
nificant for ALL incidence rates for all cancer registries
(n=127). These associations became non-significant and
smaller in magnitude, when the population source and/or
the GNP per capita were added to the relationship. Fur-
thermore, these results were unchanged when the associ-
ation were examined using the Generalised Estimating
Equations. Therefore, although we showed that lower
prevalence of H. pylori and improved sanitation is asso-
ciated with increased incidence of childhood ALL, our
findings do not conclusively support Greaves’ [9] “ delayed
infection” hypothesis.
One of the strengths in our study is the use of H. pylori
as a biomarker for sanitation. However, as ours was an eco-
logical study, various weaknesses are associated with the
study design [14]. One is ecologic bias. This means that
even though inverse associations between H. pylori preva-
lence and incidence rates of childhood ALL among popula-
tions were shown, this cannot be translated into an
increased risk of incidence of ALL in an individual child
known to be infected by H. pylori. Doing so would be erro-
neous and leads to ecologic fallacy. Ecologic bias can arise
as a result of biases within the group studied, confounding
by groups or effect modification by groups [14]. There are
also more problems in ecologic studies as compared toindividual-level studies with regards to the selection, con-
trol and analysis of confounders [14]. This was experienced
in our study. In addition, ecologic studies do not provide
assurance that disease occurrence did not precede expos-
ure [14]. Temporality is an important criterion that needs
to be met for causality in an exposure-disease relationship.
Collinearity is another limitation as certain predictors, such
as socio-demographic and environmental factors, tend to
be highly correlated with each other than they are at indi-
vidual level [14]. This is illustrated in our study, for ex-
ample, between the level of urbanization and GNP per
capita. Ecologic studies are also limited by lack of adequate
data or if available, these data may not be comparable [14].
This was certainly seen in our study as there were insuffi-
cient data on H. pylori prevalence and when available, they
were not comparable due to the different methodologies
used in the various H. pylori studies. Another limitation is
ALL incidence, especially in developing countries, may ac-
tually be higher since ALL may not have been diagnosed
and recorded for all cases.
In view of the numerous weaknesses associated with
ecologic studies, future studies looking at the association
between sanitation and the incidence of childhood ALL
should be done employing individual-level study designs,
such as case–control studies. This will be ideal as child-
hood ALL is a rare disease and sanitation and H. pylori
are not rare exposures.
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